Screener
Disc Medicine IRON EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Disc Medicine in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The source filing: Disc Medicine’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 8:33 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-205192
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Loss before income taxes | (63,453) | (33,966) |
| Income tax expense | (51) | (119) |
| Net loss | $(63,504) | $(34,085) |
| Net loss per share, basic and diluted | $(1.65) | $(1.02) |
| Weighted-average common shares outstanding, basic and diluted | 38,491,433 | 33,324,745 |
| Comprehensive loss: | ||
| Net loss | $(63,504) | $(34,085) |
| Other comprehensive (loss) income: |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Disc Medicine's EPS (basic)?
- Disc Medicine (IRON) reported EPS (basic) of -$1.65 in Q1 2026.
- How has Disc Medicine's EPS (basic) changed year-over-year?
- Disc Medicine's EPS (basic) decreased by 61.8% year-over-year, from -$1.02 to -$1.65.
- What is the long-term trend for Disc Medicine's EPS (basic)?
- Over 4 years (2021 to 2025), Disc Medicine's EPS (basic) has grown at a -38.2% compound annual growth rate (CAGR), from -$40.95 to -$5.99.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.
Ask your AI about Disc Medicine's eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude